Canada - English - Health Canada

samson produits sanitaires - alkyl dimethyl ethylbenzyl ammonium chloride; benzalkonium chloride - liquid - .8%; .8% - alkyl dimethyl ethylbenzyl ammonium chloride .8%; benzalkonium chloride .8% - disinfectants (for agents used on object)

Canada - English - Health Canada

samson produits sanitaires - benzalkonium chloride; alkyl dimethyl ethylbenzyl ammonium chloride - liquid - 3.5%; 3.5% - benzalkonium chloride 3.5%; alkyl dimethyl ethylbenzyl ammonium chloride 3.5% - disinfectants (for agents used on object)

Canada - English - Health Canada

the samson soap co ltd. - alkyl dimethyl ethylbenzyl ammonium chloride; benzalkonium chloride - liquid - 2.25%; 2.25% - alkyl dimethyl ethylbenzyl ammonium chloride 2.25%; benzalkonium chloride 2.25% - disinfectants (for agents used on object)

Canada - English - Health Canada

scandinavian formulas inc. - ascorbic acid; zinc (zinc gluconate) - tablet - 60mg; 15mg - ascorbic acid 60mg; zinc (zinc gluconate) 15mg - vitamins & minerals

Australia - English - Department of Health (Therapeutic Goods Administration)

samson medical technologies pty ltd - 47017 - syringe, general-purpose - this fpu syringe is intended for aspiration, concentration, purification, harvest and /or transfer of autologous fat.

Australia - English - Department of Health (Therapeutic Goods Administration)

samson medical technologies pty ltd -

Australia - English - Department of Health (Therapeutic Goods Administration)

samson medical technologies pty ltd - 36465 - centrifuge, general-purpose laboratory - a general-purpose laboratory centrifuge used to separate the components of suspensions by the centrifugal force. this device is intended to centrifuge patient samples, either alone or after addition of reagents or other additives.

United States - English - NLM (National Library of Medicine)

samson medical technologies llc - cefoxitin sodium (unii: q68050h03t) (cefoxitin - unii:6oev9dx57y) - cefoxitin 100 g - to reduce the development of drug-resistant bacteria and maintain the effectiveness of cefoxitin and other antibacterial drugs, cefoxitin for injection, usp should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. when culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. in the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. cefoxitin for injection, usp is indicated for the treatment of serious infections caused by susceptible strains of the designated microorganisms in the diseases listed below. - lower respiratory tract infections, including pneumonia and lung abscess, caused by streptococcus pneumoniae , other streptococci (excluding enterococci, e.g., enterococcus faecalis [formerly streptococcus faecalis ]), staphylococcus aureus (including penicillinase-producing strains), escherichia

United States - English - NLM (National Library of Medicine)

samson medical technologies, llc - ceftriaxone sodium (unii: 023z5br09k) (ceftriaxone - unii:75j73v1629) - ceftriaxone 100 g - to reduce the development of drug-resistant bacteria and maintain the effectiveness of ceftriaxone for injection and other antibacterial drugs, ceftriaxone for injection should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. when culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. in the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. ceftriaxone for injection is indicated for the treatment of the following infections when caused by susceptible bacteria: lower respiratory tract infections caused by streptococcus pneumoniae, staphylococcus aureus, haemophilus influenzae, haemophilus parainfluenzae, klebsiella pneumoniae, escherichia coli, enterobacter aerogenes, proteus mirabilis or serratia marcescens . skin and skin structure infections caused by staphylococcus aureus, staphylococcus epi

United States - English - NLM (National Library of Medicine)

samson medical technologies, l.l.c. - cefuroxime sodium (unii: r8a7m9my61) (cefuroxime - unii:o1r9fj93ed) - cefuroxime sodium 75 g